Theophylline extended-release tablets and aminophylline tablets, both drugs have a therapeutic effect on chronic obstructive pulmonary disease, the difference lies in the different components of the drug and different dosage forms.
The main ingredient of theophylline extended-release tablets is theophylline, which is suitable for the relief of wheezing symptoms in bronchial asthma, wheezing bronchitis and obstructive emphysema; it can also be used for asthma caused by cardiogenic pulmonary edema. The maintenance time is relatively long.
Adverse effects of theophylline extended-release tablets are nausea, vomiting, insomnia, etc. in the early stage, and tachycardia and arrhythmia can occur in overdose.
Hypersensitivity to the components of theophylline extended-release tablets, active peptic ulcer, uncontrolled convulsive disease patients are prohibited.
The main components of aminophylline tablets are theophylline and ethylenediamine, which are suitable for relieving wheezing symptoms in bronchial asthma, wheezing bronchitis, obstructive emphysema, etc.; they can also be used for asthma caused by cardiogenic pulmonary edema. The maintenance time is relatively short.
Adverse effects of aminophylline tablets include nausea, vomiting, insomnia, and in some patients, a sharp drop in blood pressure and tachycardia with ventricular arrhythmias.
Aminophylline tablets are contraindicated in people who are allergic to its components, active peptic ulcers, and patients with uncontrolled convulsive disorders.
The use of specific drugs should be carried out under the advice of a doctor to avoid adverse reactions.